Efficacy of Metabolic Correction in the Early Recovery Period in Patients with Ischemic Stroke

Objective. To assess the efficacy of including the formulation Cytoflavin in rehabilitation programs for patients in the early recovery period of ischemic stroke. Materials and methods. The results of rehabilitation measures were assessed in 100 patients (50 women and 50 men aged 18–85 years) in the early recovery period of ischemic stroke. Neurological and psychological investigations included the NIHSS, MMSE, and Rankin scales, the Rivermead mobility index, and a physical exercise tolerance test. Depending on the rehabilitation scheme, patients were divided into two groups. The study group included 50 patients receiving courses of verticalization and i.v. dropwise Cytoflavin infusions (20.0 ml in 250ml 5% glucose) for 14 days. The reference group consisted of 50 patients who received standard rehabilitation courses. Results and conclusions. Inclusion of Cytoflavin in the rehabilitation programs of patients with ischemic stroke increased treatment efficacy, which was apparent as decreases in the severity of neurological impairments (on the NIHSS) by 17.6% in the study group vs. 10.8% in the reference group (p < 0.05) and recovery of cognitive functions (on the MMSE) by 5.8% vs. 1.6% in the reference group (p < 0.05). In addition, there was an improvement in the recovery of arterial blood pressure, by 37.1% in the study group vs. 30.6% in the reference group (p < 0.05).

This is a preview of subscription content, access via your institution.


  1. 1.

    V. A. Parfenov and D. R. Khasanova, Ischemic Stroke, MIA, Moscow (2012).

    Google Scholar 

  2. 2.

    Z. A. Suslina, M. A. Piradov, and M. A. Domashenko, “Stroke: assessment of the problem (15 years on),” Zh. Nevrol. Psikhiatr., 114, No. 11, 5–13 (2014).

    CAS  Google Scholar 

  3. 3.

    Vibers D., Feigin V., and R. Braun, Stroke. Clinical Management [Russian translation], BINOM, Moscow (2005), 2nd ed.

  4. 4.

    Odinak M., Voznyuk I., and S. Yanishevskii, Stroke. The Ischemic Penumbra. Questions in the Pathogenesis, Pathomorphology, and Protection of Reversible Brain Damage, VMedA, St. Petersburg (2004).

    Google Scholar 

  5. 5.

    GOST R 52600.5-2008 Patient Management Protocol. Stroke, Standartinform, Moscow (2009).

    Google Scholar 

  6. 6.

    Order No. 1740n, On Approval of the Standard of Specialized Medical Care in Cerebral Infarct, Russian Ministry of Health, Dec. 29, 2012.

  7. 7.

    L. V. Stakhovskaya (ed.), Clinical Recommendations for the Management of Patients with Ischemic Stroke and Transient Ischemic Attacks, MEDpress-inform, Moscow (2017).

  8. 8.

    Verticalization of Patients during Rehabilitation. Clinical Guidelines, Moscow (2014).

  9. 9.

    V. V. Koval’chuk, Rehabilitation of Stroke Patients. A Monograph, Moscow (2016).

    Google Scholar 

  10. 10.

    I. I. Kukhtevich, N. I. Aleshina, and O. A. Levashova, “Active neuroprotective therapy in acute carotid ischemic stroke of moderate severity,” Zh. Nevrol. Psikhiatr., 12, No. 2, 38–42 (2014), https://doi.org/https://doi.org/10.17116/jnevro201411412238-42.

  11. 11.

    S. A. Rumyantseva, V. V. Afanas’ev, and E. V. Silina, “Pathophysiological basis of complex neuroprotection in cerebral ischemia,” Zh. Nevrol. Psikhiatr., 19, No. 3, 64–68 (2009).

    Google Scholar 

  12. 12.

    I. V. Damulin and E. V. Ekusheva, “Recovery after stroke and the processes of neuroplasticity,” Med. Sovet, 18, 12–19 (2014).

    Google Scholar 

  13. 13.

    V. V. Koval’chuk, T. N. Khaibullin, I. B. Zueva, et al., “Theoretical and applied principles for the neurorehabilitation of stoke patients,” Zh. Nevrol. Psikhiatr., 9, No. 2, 55–62 (2018), https://doi.org/https://doi.org/10.17116/jnevro201811809255.

  14. 14.

    S. A. Trofimova, E. E. Dubinina, O. A. Balunov, and N. V. Leonova, “Effects of drugs used in the treatment of patients with the sequelae of ischemic stroke on free-radical oxidation processes in model systems,” Klin. Farmakol. Ter., 24, No. 4, 34–37 (2015).

    Google Scholar 

  15. 15.

    E. V. Ekusheva, “Effects of succinate-containing formulations on neuroplasticity processes after ischemic stroke,” Eksperim. Klin. Farmakol., 8, No. 81, 37–44 (2018), https://doi.org/https://doi.org/10.30906/0869-2092-2018-81-8-37-44.

  16. 16.

    V. V. Zakharov and E. Yu. Kalimeeva, “Neuroprotective therapy in the acute and recovery periods of ischemic stroke,” Effektiv. Farmakoter., 33, 10–14 (2017).

    Google Scholar 

  17. 17.

    E. V. Mel’nikova, A. A. Shmonin, M. N. Mal’tseva, and G. E. Ivanova, “The modified Rankin scale – a universal tool for assessing independence and disability in patients in medical rehabilitation,” Consilium Medicum, 19, No. 2.1, 8–13 (2017).

Download references

Author information



Corresponding author

Correspondence to T. S. Poltavskaya.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 120, No. 3, Iss. 2, Stroke, pp. 49–53, March, 2020.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Poltavskaya, T.S., Bazhenov, V.A. & Volojanin, A.V. Efficacy of Metabolic Correction in the Early Recovery Period in Patients with Ischemic Stroke. Neurosci Behav Physi 51, 12–15 (2021). https://doi.org/10.1007/s11055-020-01032-8

Download citation


  • rehabilitation
  • early recovery period
  • ischemic stroke
  • verticalization
  • metabolic therapy
  • Cytoflavin